Corrected: (OFFICIAL)-BRIEF-Taro Spokesperson Says Allegations Made In U.S. Lawsuits Without Merit (May 14)
(In May 14 Brief, corrects source in headline to say Taro
spokesperson, not spokesperson of its parent Sun Pharma)
May 17 (Reuters) - Taro Pharmaceutical Industries
Spokesperson:
* BELIEVES ALLEGATIONS MADE IN U.S. LAWSUITS ARE WITHOUT
MERIT,
WILL CONTINUE TO "VIGOROUSLY DEFEND" AGAINST THEM
Further company coverage: SUN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Taro Pharmaceutical Industries
See all newsBrief: Taro Pharmaceutical Industries Says Taro Shareholders Approve Merger With Sun Pharma
Taro Pharmaceutical Industries Ltd reports results for the quarter ended in March - Earnings Summary
Taro Pharmaceutical Industries Ltd expected to post earnings of 31 cents a share - Earnings Preview
Ex-Sandoz exec gets probation for price-fixing after cooperation deal
Brief: ISS, Glass Lewis Recommend Taro Shareholders Vote For Merger With Sun Pharma